drugset / Trial / NCT00754039

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

NCT00754039

Phase 4 Completed 129 enrolled Daiichi Sankyo
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective of this study is to compare the effect of Welchol in combination with TriCor compared to TriCor alone on low-density lipoprotein cholesterol (LDL-C) in patients with high cholesterol.

Timeline

Start
2003-02
Primary completion
2003-09
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Colesevelam Other / unclassified 625 mg
Background Fenofibrate Small molecule 160 mg